Pulmonary embolism (PE) can be life-threatening and, when suspected, is usually investigated by computed tomographic pulmonary angiogram (CTPA). Concerns related to overutilization and harmful ionizing radiation have identified CTPA as an area in need of resource stewardship. 1,2 The purpose of this study was to explore interphysician variability in CTPA diagnostic yield and to identify any associated physician characteristics that could inform an intervention to reduce overuse in our institution.
with a significance of P ≤ .05. All analyses were performed using SAS statistical software (version 9.4, SAS Institute Inc). The McGill University Health Centre research ethics board approved this study.
Results | According to our analysis using GEE logistic regression, the odds of a positive CTPA decreased as the total number of scans ordered per physician increased (Table) . For each additional 10 studies ordered, the odds of a positive result decreased (odds ratio [OR] , 0.76; 95% CI, 0.73-0.79). Increasing patient age was associated with a higher diagnostic yield (OR, 1.02 per year; 95% CI, 1.01-1.03). Physician years of experience (OR, 1.01; 95% CI, 0.99-1.02; P = .39), physician sex (OR, 1.14; 95% CI, 0.79-1.63; P = .49), and studies originating from the emergency department (ER) (OR, 1.11; 95% CI, 0.75-1.65; P = .60) did not show a statistically significant association. When restricting the analysis to those studies performed by ER physicians, 123 of 974 (12.6%) were positive, and the OR for positivity for each additional 10 scans ordered decreased in a similar manner (OR, 0.74; 95% CI, 0.71-0.78).
Discussion | Our institutional yield of positive CTPA was 14.3%, which is similar to prior reported studies. [4] [5] [6] However, closer inspection demonstrated that there was substantial interphysician variability, with individual positivity rates ranging between 0% to 33.3%. Our study suggests that individual demographic features, such as specialty and professional experience are not significantly associated with diagnostic yield; however, physicians who ordered a greater volume of scans compared with their peers had a markedly reduced diagnostic yield.
Limitations. Limitations of our study included its retrospective design and the inadequate charting of parameters, which precluded the derivation of a preexamination clinical probability score. In addition, owing to limitations in data collection, we were unable to determine the denominator of patients presenting with PE-related symptoms examined by each physician. Notably, in the cohort of ER physicians shift allotment was generally randomized and we did not observe any systematic biases.
Conclusions | Among physicians who ordered a greater number of CTPA scans, we observed a statistically significant decrease in the proportion of positive results. This association may reflect a fundamental relationship between individual physician overutilization and decreasing diagnostic yield, and is deserving of greater attention. Peer-relative rates of utilization are easily quantified from electronic Invited Commentary page 413 databases, and can identify physicians most likely to benefit from individual performance feedback and decision support tools. Based on these findings, our group has designed automated yield monitoring and feedback, with the aim of closing the gap between individual physician performance in our institution. We hope this will translate to a substantial reduction in unnecessary CTPA scans along with the associated complications that may occur owing to unnecessary radiation, overdiagnosis, and overtreatment. In this issue of JAMA Internal Medicine, Chong and colleagues 3 consider the overuse of computed tomographic pulmonary angiography (CTPA) in the diagnosis of pulmonary embolism. They report on the use of "diagnostic yield" (the number of positive studies/total number of studies ordered) as a metric to help identify overuse. Low diagnostic yield results from performing CTPA in patients at low risk of pulmonary embolism. Their study found marked variation in diagnostic yield between providers, with the absolute number of CTPAs ordered being more predictive of low diagnostic yield than physician characteristics such as age, specialty, and years of experience. and suggest that diagnostic imaging is being disproportionately ordered by a select group of clinicians. Chong et al 3 make the case that low diagnostic yield can help identify physicians who may be ordering too many CTPAs in lowrisk patients. It is important to note, however, that a high diagnostic yield implies that a provider may only be ordering CTPA for the highest-risk patients, thus potentially missing the diagnosis of pulmonary embolism in some. Given that there are good estimates of the prevalence of pulmonary embolism in various clinical situations, as well as good data on the sensitivity and specificity of CTPE, an expected diagnostic yield could be calculated, and used as a standardized point of comparison. 5, 6 Even in situations where there is inadequate evidence to calculate an expected diagnostic yield, the mean diagnostic yield from a large group of physicians might suggest a reasonable starting point for analysis. What might this approach add to other implementation strategies for value-based care? One possibility is to use the electronic health record to develop real-time performance metrics, and then to use these metrics to target interventions based on the electronic record, such as decision support tools and peer comparisons toward individual clinicians. Electronic medical record platforms are sophisticated enough to keep a running calculation of a range of quality metrics per physician, such as dollars spent per diagnosis, and trends in the prescription of various analgesic classes over time. Such clinical data can then be used to provide personalized support to clinicians who are either outliers among their peers or whose metrics are far from the expected value. Such personalized approaches to feedback may be more impactful than more general low-value care alerts, such as the obligatory used of a decision support tool based on Wells' 
